We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$63.1B
AUM Growth
+$3.79B
Cap. Flow
-$1.12B
Cap. Flow %
-1.77%
Top 10 Hldgs %
32.11%
Holding
999
New
156
Increased
303
Reduced
370
Closed
127

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$1.35B
2
INSM icon
Insmed
INSM
+$197M
3
HUBB icon
Hubbell
HUBB
+$191M
4
ARGX icon
argenx
ARGX
+$164M
5
SLNO
Soleno Therapeutics
SLNO
+$161M

Sector Composition

Rank Sector Weight
1 Technology 30.31%
2 Healthcare 13.97%
3 Financials 11.89%
4 Consumer Discretionary 9.55%
5 Communication Services 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLT icon
351
Hilton Worldwide
HLT
$72.2B
$30.8M 0.05%
118,900
+4,000
+3% +$1.08M
EPRT icon
352
Essential Properties Realty Trust
EPRT
$6.61B
$30.8M 0.05%
+1,035,000
New +$31.7M
FIS icon
353
Fidelity National Information Services
FIS
$22B
$30.7M 0.05%
465,578
-5,600
-1% -$408K
FBIN icon
354
Fortune Brands Innovations
FBIN
$6.15B
$30.7M 0.05%
575,000
+524,500
+1,039% +$29.6M
NPB
355
Northpointe Bancshares
NPB
$592M
$30.6M 0.05%
1,794,104
+99,376
+6% +$1.62M
BCSS.U
356
Bain Capital GSS Investment Corp Units
BCSS.U
$30.3M 0.05%
+3,000,000
New +$30.3M
PCG icon
357
PG&E
PCG
$37.8B
$30.2M 0.05%
2,000,800
-12,100
-0.6% -$176K
AURA icon
358
Aura Biosciences
AURA
$810M
$30.2M 0.05%
4,881,125
IDA icon
359
Idacorp
IDA
$8.21B
$30.1M 0.05%
227,500
-30,000
-12% -$3.72M
GTM
360
ZoomInfo Technologies
GTM
$1.22B
$30M 0.05%
2,750,000
+124,999
+5% +$1.34M
STT icon
361
State Street
STT
$50.1B
$30M 0.05%
258,232
-3,000
-1% -$335K
CTSH icon
362
Cognizant
CTSH
$25.7B
$29.8M 0.05%
444,650
-306,800
-41% -$22.2M
IRON icon
363
Disc Medicine
IRON
$2.99B
$29.7M 0.05%
450,000
POOL icon
364
Pool Corp
POOL
$7.49B
$29.7M 0.05%
95,809
-44,730
-32% -$14M
TERN
365
DELISTED
Terns Pharmaceuticals
TERN
$29.6M 0.05%
3,939,000
+2,659,000
+208% +$17M
FAST icon
366
Fastenal
FAST
$58.9B
$29.4M 0.05%
599,908
+407,900
+212% +$19.3M
SSD icon
367
Simpson Manufacturing
SSD
$8.1B
$29.3M 0.05%
175,000
+100,000
+133% +$17.9M
LENZ
368
LENZ Therapeutics
LENZ
$167M
$29.2M 0.05%
627,618
-495,120
-44% -$18.2M
WDC icon
369
Western Digital
WDC
$148B
$28.9M 0.05%
240,837
-28,700
-11% -$2.35M
EFX icon
370
Equifax
EFX
$21.4B
$28.9M 0.05%
112,700
+18,900
+20% +$4.75M
ATAI icon
371
AtaiBeckley Inc
ATAI
$2.67B
$28.7M 0.05%
5,434,782
CTRE icon
372
CareTrust REIT
CTRE
$9.65B
$28.6M 0.05%
825,000
+90,000
+12% +$2.96M
NRG icon
373
NRG Energy
NRG
$25B
$28.5M 0.05%
176,052
-93,000
-35% -$14.5M
HUM icon
374
Humana
HUM
$45.8B
$28.5M 0.05%
109,510
-1,000
-0.9% -$263K
SO icon
375
Southern Company
SO
$107B
$28.5M 0.05%
300,300
-706,300
-70% -$65.9M

Similar funds

Adage Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Adage Capital Partners held 999 positions worth $63.1B, up 6.4% from $59.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Adage Capital Partners's Q3 2025 filing shows 156 new, 303 increased, 370 reduced and 127 closed positions. Its largest new stake was Chevron: 3,284,841 shares worth $510M. The largest sale was Hess, an estimated $1.35B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2025 buy was Chevron: 3,284,841 shares worth $510M.
  • Adage Capital Partners added most to Royalty Pharma in Q3 2025, an estimated $216M increase.
  • Adage Capital Partners's biggest Q3 2025 reduction was Insmed, cutting an estimated $197M.
  • Adage Capital Partners fully exited Hess in Q3 2025, selling an estimated $1.35B.
  • Adage Capital Partners's ten largest holdings make up 32% of its $63.1B portfolio in Q3 2025.
  • Adage Capital Partners opened 156 new positions and closed 127 in Q3 2025.
  • Adage Capital Partners's portfolio value rose 6.4% quarter-over-quarter to $63.1B.

Based on Adage Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.